Study Investigating the Pharmacokinetics, Pharmacodynamics and Safety of FE200486

NCT00117949 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

82

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: Degarelix
DRUG: Degarelix
DRUG: Degarelix
DRUG: Degarelix

Sponsor

Ferring Pharmaceuticals